BPCR - BioPharma Credit PLC - Stock & Dividends

Exchange: London Exchange • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: GB00BDGKMY29

Royalties, Debt, Life Sciences, Pharmaceuticals

BioPharma Credit PLC is a unique investment trust that focuses on investing in debt assets that generate interest income. These debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products, such as pharmaceuticals, biotechnology, and medical devices.

The trust's investment strategy is designed to provide a steady stream of income to its shareholders, while also offering a relatively low-risk profile. By investing in debt assets secured by royalties or cash flows from approved life sciences products, BioPharma Credit PLC is able to tap into the growing demand for innovative healthcare solutions.

As a London-based investment trust, BioPharma Credit PLC was incorporated in 2016 and has since established itself as a specialist in the life sciences debt investment space. With a strong focus on generating consistent income and capital preservation, the trust has become an attractive option for investors seeking exposure to the life sciences sector.

For more information about BioPharma Credit PLC, including its investment portfolio and performance, investors can visit the company's website at https://www.bpcruk.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for BPCR - BioPharma Credit PLC  - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for BPCR - BioPharma Credit PLC  - Stock & Dividends

BPCR Stock Overview

Market Cap in USD 102,648m
Sector Financial Services
Industry Asset Management
GiC SubIndustry Asset Management & Custody Banks
TER 0.00%
IPO / Inception

BPCR Stock Ratings

Growth 5y 67.5
Fundamental 24.4
Dividend 92.67
Rel. Performance vs Sector -1.53
Analysts -
Fair Price Momentum 0.95 USD
Fair Price DCF 2.66 USD

BPCR Dividends

Dividend Yield 12m 17.79%
Yield on Cost 5y 24.57%
Dividends CAGR 5y 8.06%
Payout Consistency 95.0%

BPCR Growth Ratios

Growth 12m 17.97%
Growth Correlation 12m 45%
Growth Correlation 3m -8%
CAGR 5y 6.67%
CAGR/Mean DD 5y 2.15
Sharpe Ratio 12m 0.89
Alpha vs SP500 12m 9.92
Beta vs SP500 5y weekly 0.14
ValueRay RSI 83.07
Volatility GJR Garch 1y 7.73%
Price / SMA 50 3.57%
Price / SMA 200 6.1%
Current Volume 1546.9k
Average Volume 20d 1683.9k

External Links for BPCR Stock

Fund Manager Positions
What is the price of BPCR stocks?
As of July 19, 2024, the stock is trading at USD 0.87 with a total of 1,546,949 shares traded.
Over the past week, the price has changed by +0.23%, over one month by +5.19%, over three months by +1.58% and over the past year by +17.41%.
What are the forecast for BPCR stock price target?
According to ValueRays Forecast Model, BPCR BioPharma Credit PLC will be worth about 1 in July 2025. The stock is currently trading at 0.87. This means that the stock has a potential upside of +19.54%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 1 19.5